Jump to any asset
849 assets, updated daily
As of October 11, 2026, IQVIA Holdings Inc. (IQV) trades at $259.88. CleaRank Financial AI rates it Hold with a fair value of $280.00, 7.7% above the current price. Wall Street's consensus target is $280.00 across 22 analysts. RSI at 39 is in neutral territory, and the price is above its 50-day average of $256.86.
IQVIA Holdings Inc. (IQV)
IQVIA Holdings Inc. NYSE
$259.88
1.000 (0.39%)
At close: Oct 9, 4:00 PM EDT
AI Analyst Consensus
50 / 100
IQVIA Holdings Inc. (IQV) is trading at $259.88, above its 50-day and 200-day moving averages ($256.86 and $206.79), indicating a bearish trend. The company operates in the Healthcare sector, specifically Diagnostics & Research, and competes with other major players like PFE and JNJ. Despite a recent downgrade to 'Equal-Weight' by Morgan Stanley, the overall Wall Street consensus remains 'Buy' with a median price target of $280.00, suggesting a 7.7% upside potential. Fundamental analysis shows IQV's P/E ratio of 32.28 is slightly above the sector median of 31.9, while its price-to-sales ratio of 2.52 is below the sector median of 3.7. The company boasts a strong return on equity of 22.82% and a profit margin of 8.10%, exceeding sector averages. However, a significant concern is the heavy insider selling, with over $52.6 million in dispositions reported, signaling potential headwinds.
IQV Price Analysis
Market Metrics
Open
$257.73
Day Range
$257.73 to $263.51
Prev Close
$258.88
Volume
972.3K
52-Week Range
$154.50 to $277.40
Market Cap
$42.78B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Valuation is broadly in line with sector peers (1% difference), suggesting fair market pricing relative to industry standards.
IQV Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 2 quarters, IQV beat estimates 2 times. However, the stock fell 2 times the next day. This suggests positive news is often "priced in" or investors are selling the news.
IQV Analysis
Company's Health
3/5
12-Month Analyst Target
+7.74% Upside
Median of 22 analysts (12-month)
$280.00
AI Technical Analysis
IQVIA Holdings Inc. (IQV) is currently trading above its 50-day and 200-day moving averages ($256.86 and $206.79), indicating a bearish trend. The Relative Strength Index (RSI) is at 38.95, signaling bearish momentum. The Moving Average Convergence Divergence (MACD) is positive at 0.81, but the overall chart structure suggests a potential for further downside. Key support levels are not clearly defined due to recent price action, but the 50-day SMA at $256.86 and the 200-day SMA at $206.79 are important reference points. Volume has been below average recently, suggesting a lack of strong conviction from buyers. The stock's position below its 20-day EMA at $262.98 further reinforces the bearish short-term outlook.
ProTips
- Monitor insider transactions closely; significant selling pressure could indicate future headwinds for IQV.
- A sustained move above the 50-day SMA at $256.86 would be a key technical signal for a potential trend reversal.
- Consider the impact of the recent earnings beats on future analyst estimates and potential price target revisions.
Key Catalysts
Bullish
Consistent Earnings Beats
IQVIA has a track record of beating analyst EPS estimates, as seen in the June 2026 and December 2025 quarters, suggesting operational strength and accurate forecasting.
Source: Earnings ReportsBearish
Heavy Insider Selling
Over $52.6 million in insider sales have been reported, indicating potential concerns among management regarding the current stock valuation or future prospects.
Source: Insider TransactionsBearish
Bearish Technical Momentum
The stock is trading below its key moving averages (50-day, 200-day, and 20-day EMA) with a bearish RSI status, suggesting potential for further price declines.
Source: Technical AnalysisNeutral
Wall Street 'Buy' Consensus
Despite some recent downgrades, the majority of Wall Street analysts maintain a 'Buy' rating, providing a floor for the stock price and indicating underlying confidence.
Source: Analyst RatingsMarket Outlook
IQVIA Holdings Inc. (IQV) is expected to see continued revenue growth in the coming years, with analysts projecting 7.00% for the current year and 6.00% for the next. The company's strong profitability metrics and consistent earnings beats provide a foundation for potential upside. The median Wall Street price target of $280.00 suggests a 7.7% appreciation from the current price. However, the outlook is tempered by significant insider selling and bearish technical indicators. A sustained break above the 50-day SMA at $256.86 and the 20-day EMA at $262.98 would be needed to signal a shift in momentum. Investors should monitor insider activity closely, as further selling could pressure the stock, while a reversal in insider sentiment could act as a bullish catalyst.
Key Statistics
| Market Cap | 42.78B |
|---|---|
| P/E Ratio | 32.28 |
| EPS (TTM) | 8.05 |
| Dividend Yield | 0.00% |
| 52 Week High | 277.40 |
| 52 Week Low | 154.50 |
IQVIA Holdings Inc. (IQV) presents a mixed fundamental picture with a P/E ratio of 32.28, slightly above the sector median of 31.9, and a price-to-sales ratio of 2.52, which is below the sector median of 3.7. The company demonstrates strong profitability with a return on equity of 22.82% and a net profit margin of 8.10%, both significantly outperforming sector averages. Its debt-to-equity ratio of 2.58 is also within a reasonable range compared to the sector average of 2.58. Despite strong profitability metrics, the significant insider selling totaling over $52.6 million raises concerns about management's near-term confidence in the stock's valuation. While revenue growth of 8.7% is solid and aligns with the sector average of 8.1%, the current valuation may not fully account for potential risks indicated by insider actions.
Earnings & Growth Analysis
IQVIA Holdings Inc. (IQV) recently reported earnings for the quarter to June 2026, with an actual EPS of $-0.02 against an estimate of $-0.11, representing an 81.82% surprise beat. This was followed by a 0.03% price decrease. Prior to that, for the quarter to December 2025, the company reported an EPS of $0.50 versus an estimate of $0.44, a 13.64% surprise beat, with a 1.5% price decrease. The company has shown a pattern of beating earnings estimates, which is a positive sign for its operational performance.
Key Risks
The primary risk for IQVIA Holdings Inc. (IQV) stems from significant insider selling, with over $52.6 million in dispositions, which could signal a lack of confidence in the current valuation. Additionally, the stock is trading below key moving averages, indicating bearish technical momentum and a potential for further price declines. Competitive pressures within the Healthcare Diagnostics & Research sector also pose a continuous risk to market share and profitability.
Technical Indicators
| RSI (14) | 38.95 |
|---|---|
| MACD | 0.81 |
| SMA 50 | 256.86 |
| SMA 200 | 206.79 |
RSI
Bearish
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($256.86) above the 200-day SMA ($206.79), price action is firmly bullish above key moving averages.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.42
Moderate correlation
Nasdaq 100 (QQQ)
+0.32
Weak correlation
Bitcoin (BTC)
+0.19
Weak correlation
Gold (XAU)
+0.02
Weak correlation
Check Custom Correlation
How does any other asset move with IQV? One year of daily closes, Pearson correlation.
Try
IQV Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies pick an entry style
Conservative
$257.28
Slight discount to current
Wait for small dip
Aggressive
$259.88
At current price
Enter now if confident
Risk Management
STOP LOSS
$248.64
MAX LOSS
-3.4%
Volatility-Adjusted Stop Loss
Calculated based on RSI (39.0) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$265.00
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$270.15
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$277.86
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for IQV is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on October 11, 2026.Growth of $10,000
A $10,000 investment in IQV in October 2016 would be worth about $33,650 today, compared with about $36,479 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in IQV today could grow to about $25,898 by 2036 in the base case, with a bull case near $95,853 and a bear case around $6,997. Projections are statistical simulations, not guarantees.
IQV Stock Price Prediction: 2030
CleaRank's simulation projects a price near $380 for IQV by 2030 in the base case, from $260 today (1.5x over 4 years). The downside path ends near $166. These are outcomes of a Monte Carlo simulation run on IQV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $189 | $286 | $432 |
| 2028 | $175 | $314 | $564 |
| 2029 | $169 | $346 | $708 |
| 2030 | $166 | $380 | $870 |
| 2031 | $166 | $418 | $1,055 |
| 2032 | $167 | $460 | $1,268 |
| 2033 | $169 | $506 | $1,512 |
| 2034 | $173 | $556 | $1,794 |
| 2035 | $177 | $612 | $2,118 |
| 2036 | $182 | $673 | $2,491 |
Method: 10,000 simulated price paths using IQV's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
IQV Insider Trading Analysis
Bought
None
No open-market buys
Sold
$52.6M
11 Transactions
Insiders
14
Active Traders
Avg Transaction
$4.8M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2018 | CPP INVESTMENT BOARD PRIVATE HOLDINGS INC
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 9.3M | $957.0M |
| Nov 30, 2017 | CPP INVESTMENT BOARD PRIVATE HOLDINGS INC
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 7.5M | $764.8M |
| Jun 15, 2018 | TPG GROUP HOLDINGS SBS ADVISORS INC
Unknown
|
Sell | 6.7M | $691.8M |
| Jun 15, 2018 | TPG GROUP HOLDINGS SBS ADVISORS, INC.
Unknown
|
Sell | 6.7M | $691.8M |
| Mar 8, 2019 | TPG GROUP HOLDINGS SBS ADVISORS, INC.
Director
|
Sell | 4.0M | $569.5M |
| Nov 30, 2017 | TPG GROUP HOLDINGS SBS ADVISORS INC
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 5.4M | $552.8M |
| Nov 30, 2017 | TPG GROUP HOLDINGS SBS ADVISORS, INC.
Director and Beneficial Owner of more than 10% of a Class of Security
|
Sell | 5.4M | $552.8M |
| Feb 13, 2020 | TPG GROUP HOLDINGS SBS ADVISORS, INC.
Unknown
|
Sell | 3.0M | $492.3M |
| Jul 28, 2020 | TPG GROUP HOLDINGS SBS ADVISORS, INC.
Unknown
|
Sell | 2.9M | $464.5M |
| Dec 4, 2018 | TPG GROUP HOLDINGS SBS ADVISORS, INC.
Unknown
|
Sell | 3.6M | $442.1M |
Page 1 of 1
Frequently Asked Questions
What is IQVIA's stock price forecast for 2030?
IQVIA's stock price forecast for 2030, based on Monte Carlo simulations, projects a base case of $380.26, with a downside scenario at $166.2 and an upside scenario at $870.02. These are statistical outcomes, not guaranteed price targets.
Is IQVIA Holdings Inc. stock a buy right now?
IQVIA Holdings Inc. (IQV) is currently rated as 'Hold' by our AI consensus, with a score of 50. Wall Street analysts have a 'Buy' rating with a median price target of $280.00, suggesting a modest upside from the current price of $259.88.
What are the biggest risks facing IQVIA Holdings Inc.?
The most significant risks for IQVIA include heavy insider selling totaling over $52.6 million, bearish technical momentum indicated by RSI and moving average positioning, and ongoing competitive pressures within the healthcare diagnostics and research sector.
How has IQVIA performed in recent earnings reports?
IQVIA has demonstrated a pattern of beating earnings estimates in its recent reports. For the quarter to June 2026, EPS was $-0.02 against an estimate of $-0.11 (81.82% beat), and for the quarter to December 2025, EPS was $0.50 versus an estimate of $0.44 (13.64% beat).
What is IQVIA's valuation compared to its sector peers?
IQVIA's P/E ratio of 32.28 is slightly above the Healthcare sector median of 31.9, while its price-to-sales ratio of 2.52 is below the sector median of 3.7. The company's return on equity of 22.82% significantly outperforms the sector average of 6.9%.
What is the Wall Street consensus on IQVIA stock?
The Wall Street consensus for IQVIA (IQV) is 'Buy', with 22 analysts covering the stock. There are 3 'Strong Buy' ratings, 16 'Buy' ratings, and 3 'Hold' ratings, contributing to a Wall Street score of 75 out of 100.
How does IQVIA's revenue growth compare to the sector?
IQVIA's reported revenue growth is 8.7%, which is slightly higher than the Healthcare sector median revenue growth of 8.1%. Analyst estimates project continued growth, with current year revenue growth expected at 7.00% and next year at 6.00%.